Biote Corp (BTMD)
6.14
+0.08
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
6.13
-0.01
(-0.16%)
After-Hours: 20:00
Biote Debt to Equity Ratio: -0.9114 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.9114 |
| June 30, 2024 | -0.8383 |
| March 31, 2024 | -3.150 |
| December 31, 2023 | -3.840 |
| September 30, 2023 | -2.819 |
| June 30, 2023 | -2.491 |
| Date | Value |
|---|---|
| March 31, 2023 | -2.410 |
| December 31, 2022 | -2.662 |
| September 30, 2022 | -3.220 |
| June 30, 2022 | -4.852 |
| March 31, 2022 | |
| December 31, 2021 | 8.961 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.852
Minimum
Jun 2022
8.961
Maximum
Dec 2021
-1.658
Average
-2.662
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| American Shared Hospital Services | 0.8485 |
| Omnicell Inc | 0.4645 |
| Astrana Health Inc | 0.6218 |
| Cryo-Cell International Inc | -1.122 |
| P3 Health Partners Inc | 1.107 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 101.25M |
| Total Liabilities (Quarterly) | 228.08M |
| Shareholders Equity (Quarterly) | -130.34M |
| Current Ratio | 1.505 |
| Net Debt Paydown Yield | -0.37% |